Not all cardiac arrests can be treated with an electric shock. In fact, most of them—about 80%—are ineligible for defibrillation. With a survival rate of about 4%, these deaths continue to number ...

Danish medtech company Neurescue has gained a European CE mark for its catheter to address non-shockable cardiac arrest. The company’s catheter is used in conjunction with a handheld control unit to ...

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a new study. Cardiac ...

Lowering the body's temperature in cardiac arrest patients with 'non-shockable' heart rhythms increases survival and brain function. Patients who received the treatment were about three times more ...

COPENHAGEN, Denmark, September 09, 2025--(BUSINESS WIRE)--Neurescue ApS today announced CE Mark approval for the NEURESCUE ® device, the first and only medical device approved to treat non-shockable ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

Incremental cost-effectiveness ratio was $4,481,659 per quality-adjusted life-year for AED in a private home. (HealthDay News) — For patients with cardiac arrest and a shockable rhythm, automated ...

Research indicates that non-shockable cardiac arrest is associated with higher mortality rates compared to cardiac arrest cases wherein shockable rhythms such as ventricular fibrillation or pulseless ...